Most patients lose weight in a predictable arc, and knowing the shape of it helps you stay patient through the early weeks.
Both semaglutide and tirzepatide begin working within days, but the change you feel first is not the number on the scale. These medications are GLP-1 drugs, meaning they mimic a gut hormone that signals fullness to your brain. Most people notice reduced appetite and smaller portions in the first week or two, well before meaningful weight loss shows up.
That gap between how you feel and what you weigh trips up a lot of people. The appetite effect starts fast because the medication acts on hunger signaling almost immediately. Measurable weight change takes longer, since it depends on a sustained calorie deficit building up over weeks as your dose rises.
The rest of this guide maps that arc stage by stage, from the cautious starting dose through the typical plateau range, so you know what each phase should realistically look like.
The first month is about letting your body adjust to the medication, not chasing numbers on the scale. Both semaglutide and tirzepatide start at low doses on purpose. Semaglutide typically begins at 0.25mg per week, and tirzepatide begins at 2.5mg per week. At these starting amounts, your appetite starts to quiet down, but visible weight change is usually small or uneven.
Most of what you notice in weeks 1 through 4 is appetite. Many patients feel full sooner, think about food less often, and finish smaller portions without effort. Some also feel mild nausea, constipation, or fatigue as their digestion adapts. Those side effects tend to ease within a couple of weeks, which is exactly why the starting dose stays low.
Starting conservatively is a clinical choice, not a slow start for its own sake. A lower opening dose gives your gut time to adjust and reduces the odds of side effects strong enough to make you want to quit. At Optima, your nurse practitioner sets and adjusts that opening dose based on how you respond, rather than pushing you up a fixed schedule regardless of how you feel.
If the scale barely moves in week two, that is normal. This early phase builds the tolerance that makes the steadier loss in the months ahead possible.
By your second month, your provider steps the dose up, and the scale starts to reflect it. Semaglutide typically climbs toward 1mg per week over this stretch, while tirzepatide moves toward the 5mg to 7.5mg range. Appetite suppression that felt subtle in the early weeks now shows up as consistent weekly and monthly loss, because a higher dose gives your body a stronger, steadier signal that you are full.
Most patients see the pace turn from barely-there to clearly visible during these weeks. Many notice a few pounds most weeks rather than a stubborn flat line, though the exact number depends on your starting weight, your habits, and how your body responds. These are typical ranges, not promises, and your nurse practitioner adjusts the pace based on how you feel and how you tolerate each step.
Tirzepatide tends to pull ahead of semaglutide at comparable points in this phase. Because tirzepatide acts on two hunger-related pathways instead of one, its average loss at equivalent months often runs somewhat higher for many patients. That gap is a general pattern, not a guarantee for any one person. Some people do beautifully on semaglutide and never need to consider the alternative, which is exactly why Optima matches the medication and dose to you rather than defaulting to the strongest option.
By months four through six, most patients reach their maintenance dose range. Semaglutide often sits around 1.7mg to 2mg by this point, and tirzepatide frequently reaches 10mg to 15mg. Steady appetite control has held for months now, and the results start to compound because the medication and your behavior changes work together. Smaller portions feel normal, and the eating patterns you built early on stop feeling like effort.
Weight loss during this stretch is often the most visible on the scale, though it varies widely from person to person. Some patients keep losing steadily. Others slow down as their body settles into a new pattern. Both are normal.
Provider check-ins at this stage are about calibration, not automatic escalation. Your nurse practitioner at Optima looks at how you're responding, how you feel, and whether your current dose is still working before adjusting anything. If a lower dose keeps producing results, there's no reason to push higher. The goal is the least amount of effective medication for your body, not the highest number your tolerance allows.
By month six, most patients have moved through their full titration schedule and start to see where their body settles. Many people who stay consistent with a GLP-1 program lose somewhere in the range of 10 to 20 percent of their starting body weight over 6 to 12 months. Tirzepatide tends to land toward the higher end of that range at comparable timepoints, while semaglutide often falls somewhat lower on average. Weight loss usually slows here rather than stopping, and reaching a plateau means your body has found a new balance at your current dose.
A plateau is not a failure. Your nurse practitioner reviews your progress and decides whether holding steady, adjusting the dose, or focusing on maintenance makes the most sense for your goals. Some people keep losing gradually past month six. Others hold their new weight, which is its own kind of success.
Please note. The 10 to 20 percent range describes typical outcomes reported across GLP-1 studies and clinical experience. It is not a guarantee. Individual results vary based on your starting weight, dose, metabolism, and how closely you pair the medication with diet and activity changes. This information is educational and does not replace personalized guidance from your provider.
The stage-by-stage map above describes a typical arc, but your provider adapts it to you. Four levers move your personal timeline: how fast you titrate up, how consistently you pair the medication with diet and activity changes, how your metabolism responds, and how reliably you inject on schedule. Change any one of these and the curve shifts.
A slower titration protects you from side effects. When your nurse practitioner steps the dose up gradually, your gut has time to adjust, and nausea or fatigue stays manageable. That patience shifts your timeline later, not worse. You reach the same range, you just take a steadier path to get there.
People respond differently at the same dose, and neither pattern is a problem. Some patients settle at a small dose, lose steadily, and stay there for the whole program. Others tolerate the medication easily and need a higher dose to keep seeing results. One is not more successful than the other. Your body decides which one you are.
Optima does not push everyone toward a ceiling dose by default. The clinic's approach is to find the least amount of effective medication for your goals and tolerance, then adjust from your actual response rather than a preset escalation schedule. Higher is not automatically better, and your nurse practitioner treats dose as a tool to calibrate, not a target to max out.
Minimum-effective dosing protects your wallet as much as your comfort. Because Optima's programs are vial-based and you pay for the medication your body needs, using the smallest dose that works keeps your cost predictable instead of climbing every time you titrate. Good clinical care and fair pricing point the same direction here.
Both drugs follow the same low-and-slow logic, but their milligram scales run differently, so a "5mg" of one is not comparable to a "5mg" of the other. The table below lines up the typical dosing at each stage discussed above, so you can see the pacing at a glance. These are common ranges a provider titrates toward, not fixed rules, and your nurse practitioner adjusts them to your response and tolerance.
Tirzepatide tends to show somewhat greater average loss at comparable stages, which is why many patients and providers consider it when a faster arc fits their goals. Neither drug is automatically the right choice. The best fit depends on your history, your tolerance, and what your provider recommends after a consult.
The timeline above holds up because you know the cost before you start. Optima Tyler runs GLP-1 care as fixed-duration, vial-based programs, not monthly subscriptions that climb every time your dose steps up. Semaglutide runs $249 for 10 weeks, and tirzepatide runs $499 for 10 weeks. That price covers your medication, supplies, consultation, and shipping, so a higher dose during titration does not mean a higher bill mid-program.
A subscription model ties your monthly cost to your dose, which quietly penalizes the exact upward titration that drives results in months 2 through 6. The fixed-duration structure removes that pressure. You and your provider can move at the pace your body needs, guided by the least effective dose rather than the cheapest one.
The same licensed nurse practitioner manages your titration from the first consult through follow-up. You can be seen in person at the Tyler clinic or over telehealth anywhere in Texas, with medication shipped discreetly to your door. A consistent provider who knows your response, paired with predictable pricing, is what turns the stages above from a generic chart into a plan built around you.
How soon will I actually lose weight? Most patients notice appetite changes within the first week, but visible scale movement usually starts around weeks 3 to 4 as the dose builds. Real, steady loss tends to show up in months 2 and 3. Your provider tracks this so you know whether you are on a typical curve for you.
Why isn't the scale moving in weeks 1 to 2? The starting dose is intentionally low to build tolerance and limit nausea, so it does not drive much loss yet. Early water shifts and appetite changes can also mask progress on the scale. Focus on how full you feel, not the number, during this stretch.
Does tirzepatide work faster than semaglutide? On average, tirzepatide tends to produce somewhat greater weight loss at comparable timepoints, partly because it acts on two hormone pathways instead of one. That said, individual response varies, and many patients do very well on semaglutide. Your provider helps you weigh which fits your goals and budget.
What happens if I plateau? Plateaus are normal, and they do not mean the medication stopped working. Your nurse practitioner reviews your dose, adherence, and habits to decide whether a small adjustment makes sense.
Can my provider adjust my dose? Yes. At Optima Tyler, the same nurse practitioner manages your titration and adjusts pace to your response and tolerance, aiming for the least effective dose rather than automatic escalation.
Your timeline starts with a conversation, not a shipped box. A licensed nurse practitioner reviews your health, sets your starting dose, and builds a plan around your goals and tolerance rather than a fixed script. You can meet in person at our Tyler clinic or connect by telehealth anywhere in Texas, with your medication delivered discreetly to your door.
The same provider stays with you through every titration step, so you always know who is guiding your dose.
Book your consultation online or call (903) 459-6864 to get started. Less weight. More life. It begins with one appointment.